Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,185,988
in 8 filings, $4.8M under 10b5-1 plans

Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-01 Eydelman Mikhail SVP, Gen Counsel & Corp Sec Grant or award +13,750 21,782
2023-03-01 Eydelman Mikhail SVP, Gen Counsel & Corp Sec Grant or award · Stock Option (right to buy) +82,500 82,500
2023-03-01 Wassil Jim Chief Operating Officer Grant or award +22,500 170,215
2023-03-01 Wassil Jim Chief Operating Officer Grant or award · Stock Option (right to buy) −135,000 135,000
2023-03-01 GUGGENHIME ANDREW President and CFO Grant or award +22,500 83,729
2023-03-01 GUGGENHIME ANDREW President and CFO Grant or award · Stock Option (right to buy) +135,000 135,000
2023-03-01 PICKERING GRANT Chief Executive Officer Grant or award +53,875 428,351
2023-03-01 PICKERING GRANT Chief Executive Officer Grant or award · Stock Option (right to buy) +323,250 323,250
2023-01-10 Lukatch Heath Director Exercise or conversion +315 $16.00 $5K 3,440
2023-01-10 Lukatch Heath Director Sale −233 $46.04 $11K 3,207
2023-01-10 Lukatch Heath Director Sale −82 $46.33 $4K 3,125
2023-01-10 Lukatch Heath Director Exercise or conversion · Stock Option (right to buy) −315 28,000
2022-12-30 Fairman Jeff VP, Research Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-12-30 Dhaliwal Harpreet S. SVP Cml Mfg & Supply Chain Grant or award · Stock Option (right to buy) +15,000 15,000
2022-12-30 Sauer Paul SVP Process Dev, Manufacturing Grant or award · Stock Option (right to buy) +15,000 15,000
2022-12-30 Eydelman Mikhail SVP, Gen Counsel & Corp Sec Grant or award · Stock Option (right to buy) +27,500 27,500
2022-12-30 Wassil Jim Chief Operating Officer Grant or award · Stock Option (right to buy) +42,000 42,000
2022-12-30 GUGGENHIME ANDREW President and CFO Exercise or conversion +23,691 $5.35 $127K 61,229
2022-12-30 GUGGENHIME ANDREW President and CFO Grant or award · Stock Option (right to buy) +42,000 42,000
2022-12-30 GUGGENHIME ANDREW President and CFO Exercise or conversion · Stock Option (right to buy) −23,691 430,827

Page 42 of 51 · 1,004 trades